Countdown to Ethereum Pectra Upgrade Activation: Learn more
$3.11T
Total marketcap
$82.23B
Total volume
BTC 62.25%     ETH 7.11%
Dominance

DexCom DXCM Stock

81.74 USD {{ price }} 0.251413% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
32.05B USD
LOW - HIGH [24H]
80.5 - 82.09 USD
VOLUME [24H]
453.43K USD
{{ volume }}
P/E Ratio
61.45
Earnings per share
1.33 USD

DexCom Price Chart

DexCom DXCM Financial and Trading Overview

DexCom stock price 81.74 USD
Previous Close 127.06 USD
Open 128.32 USD
Bid 0 USD x 800
Ask 0 USD x 800
Day's Range 128.1 - 131.24 USD
52 Week Range 67.74 - 131.24 USD
Volume 4.12M USD
Avg. Volume 2.3M USD
Market Cap 50.77B USD
Beta (5Y Monthly) 1.144718
PE Ratio (TTM) 184.47887
EPS (TTM) 1.33 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 140.7 USD

DXCM Valuation Measures

Enterprise Value 48.83B USD
Trailing P/E 184.47887
Forward P/E 87.32
PEG Ratio (5 yr expected) 3.73
Price/Sales (ttm) 16.7982
Price/Book (mrq) 22.735636
Enterprise Value/Revenue 16.155
Enterprise Value/EBITDA 90.19

Trading Information

DexCom Stock Price History

Beta (5Y Monthly) 1.144718
52-Week Change 90.35%
S&P500 52-Week Change 20.43%
52 Week High 131.24 USD
52 Week Low 67.74 USD
50-Day Moving Average 119.91 USD
200-Day Moving Average 110.25 USD

DXCM Share Statistics

Avg. Volume (3 month) 2.3M USD
Avg. Daily Volume (10-Days) 2.87M USD
Shares Outstanding 387.64M
Float 384.55M
Short Ratio 5.58
% Held by Insiders 0.40%
% Held by Institutions 100.06%
Shares Short 14.26M
Short % of Float 4.16%
Short % of Shares Outstanding 3.67%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 4:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 9.67%
Operating Margin (ttm) 13.13%
Gross Margin 64.43%
EBITDA Margin 17.91%

Management Effectiveness

Return on Assets (ttm) 4.69%
Return on Equity (ttm) 13.22%

Income Statement

Revenue (ttm) 3.02B USD
Revenue Per Share (ttm) 7.77 USD
Quarterly Revenue Growth (yoy) 17.89%
Gross Profit (ttm) 1.88B USD
EBITDA 541.4M USD
Net Income Avi to Common (ttm) 292.5M USD
Diluted EPS (ttm) 0.71
Quarterly Earnings Growth (yoy) -50.10%

Balance Sheet

Total Cash (mrq) 2.57B USD
Total Cash Per Share (mrq) 6.62 USD
Total Debt (mrq) 2.14B USD
Total Debt/Equity (mrq) 95.96 USD
Current Ratio (mrq) 2.02
Book Value Per Share (mrq) 5.761

Cash Flow Statement

Operating Cash Flow (ttm) 753.9M USD
Levered Free Cash Flow (ttm) 429.06M USD

Profile of DexCom

Country United States
State CA
City San Diego
Address 6340 Sequence Drive
ZIP 92121
Phone 858 200 0200
Website https://www.dexcom.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 7500

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices for specific and permitted use cases, including non-medical device applications, medical device data analysis, integrated continuous glucose monitoring systems (iCGM) secondary display alarms, active patient monitoring, and treatment decisions; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

Q&A For DexCom Stock

What is a current DXCM stock price?

DexCom DXCM stock price today per share is 81.74 USD.

How to purchase DexCom stock?

You can buy DXCM shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for DexCom?

The stock symbol or ticker of DexCom is DXCM.

Which industry does the DexCom company belong to?

The DexCom industry is Medical Devices.

How many shares does DexCom have in circulation?

The max supply of DexCom shares is 392.11M.

What is DexCom Price to Earnings Ratio (PE Ratio)?

DexCom PE Ratio is 61.45488700 now.

What was DexCom earnings per share over the trailing 12 months (TTM)?

DexCom EPS is 1.33 USD over the trailing 12 months.

Which sector does the DexCom company belong to?

The DexCom sector is Healthcare.

DexCom DXCM included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
S&P 500 INDEX SPX 5606.91 USD
-0.77
2.79B USD 2.79B USD
NASDAQ Composite IXIC 17733.55 USD
+0.25
1.04B USD 17689.28 USD 17738.65 USD 1.04B USD
S&P 500 (Yahoo.com) GSPC 5623.84 USD
+0.3
221.46M USD 5613.32 USD 5626.29 USD 221.46M USD
US100 NDX 19834.33 USD
+0.22
105.59M USD 19787.54 USD 19839.6 USD 105.59M USD
NASDAQ 100 Equal Weighted NDXE 7505.11 USD
+0.3
7481.53 USD 7513.9 USD
Nasdaq-100 Notional Net Return XNDXNNREUR 3635.68 EUR 3974.29 USD
+0.17
3622.39 EUR 3959.76 USD 3639.18 EUR 3978.12 USD
Nasdaq-100 Micro Index XND 198.6 USD
+0.35
197.86 USD 198.68 USD
NASDAQ 100 After Hours Indicato QIV 19984.88 USD
+0.98
19707.5 USD 20006.3 USD
NQ US Medical Supplies Large M NQUSB4537LMN 3087.37 USD
<0.01
3057.02 USD 3124.33 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2840.84 USD
+0.52
2828.83 USD 2844.35 USD
NASDAQ 100 Ex Tech Sector NDXX 5599.96 USD
+0.5
5584.6 USD 5607.29 USD
Nasdaq-100 ESG JPY Index NDXESG07 1891.2 JPY 12.77 USD
+0.66
1881.26 JPY 12.7 USD 1891.82 JPY 12.77 USD
NASDAQ-100 PM Settlement Value XQC 18276.41 USD
+2.63
18521.48 USD 18521.48 USD
NASDAQ 100 Notional Net Total R XNDXNNR 23001.34 USD
+0.35
22914.66 USD 23009.66 USD
NASDAQ HealthCare IXHC 907.75 USD
+0.09
905.72 USD 910.16 USD
NASDAQ Composite Total Return I XCMP 21738.2 USD
+0.38
21656.21 USD 21751.84 USD
NASDAQ 100 Pre Market Indicator QMI 19819.63 USD
+0.14
19819.2 USD 19872.9 USD
NASDAQ-100 Reduced Value Index NQX 3972.4 USD
+0.36
3957.18 USD 3974.54 USD
NASDAQ Global Select Market Com NQGS 8686.75 USD
+0.35
8656.35 USD 8688.52 USD
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD 2100.38 AUD 1390.15 USD
<0.01
2100.38 AUD 1390.15 USD 2100.38 AUD 1390.15 USD